Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...

The Sacklers could contribute an additional $500 million to the settlement if their earnings from the sale of their ...

Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...

The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the ...

Other programs could make aggressive overtures toward Purdue stars Braden Smith and Trey Kaufman-Renn, while Matt Painter is ...

Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of ...

After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...

Purdue Pharma Submits Opioid Lawsuit Settlement Plan, Including up to $7 Billion Cash From Sacklers Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan ...

NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...